A study conducted by the University of Ottawa Heart Institute revealed a possible relationship between mRNA COVID-19 vaccinations and the escalation of myocarditis/pericarditis diagnoses across the country.
According to the study’s researchers, they correlated data gathered between June 1 to July 31, 2021, concerning individuals who were administered Pfizer-BioNTech and Moderna COVID-19 vaccines and those who needed hospital care due to heart and chest-related symptoms. These data included patient records obtained from the Public Health Agency of Ottawa.
Upon going through the information within the two month period, the study’s proponents found out that several of the persons who were given the Pfizer-BioNTech and Moderna COVID-19 shots developed heart and chest-related symptoms within a few days after receiving the vaccine. They were also eventually admitted to the University of Ottawa Heart Institute for medical observation and care.
Although it is still early to provide a concrete conclusion, the research team from the University of Ottawa Heart Institute postulate that there may be a “temporal relationship between mRNA COVID vaccination, symptoms, and findings.” As of now, they theorize that 1 in 1,000 mRNA vaccinations leads to myocarditis/pericarditis, or even myopericarditis, a complication of acute pericarditis.
